These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 325809)

  • 41. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection.
    Davenport A; Younie ME; Parsons JE; Klouda PT
    Nephrol Dial Transplant; 1994; 9(9):1315-9. PubMed ID: 7816298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histocompatibility and the success of intrafamilial renal transplantation.
    Turcotte JG; Haines RF; Feduska NJ
    Surg Gynecol Obstet; 1972 Aug; 135(2):193-8. PubMed ID: 4559044
    [No Abstract]   [Full Text] [Related]  

  • 44. Cytotoxic antibodies to B lymphocytes in kidney transplant patients.
    Luciani G; Castagneto M; Monari C; Renna E
    Transplant Proc; 1979 Jun; 11(2):1265-6. PubMed ID: 382503
    [No Abstract]   [Full Text] [Related]  

  • 45. Graft survival with high levels of cytotoxic antibodies.
    Feduska NJ; Amend WJ; Vincenti F; Perkins HA; Opelz G; Terasaki PI; Iwaki Y; Duca R; Dodge D; Salvatierra O
    Transplant Proc; 1981 Mar; 13(1 Pt 1):73-80. PubMed ID: 7022910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of antiglobulin microcytotoxicity test and mixed leukocyte culture to evaluate prognosis in renal transplant recipients.
    Farrow SS; Rossen RD; Suki WN; Hersh EM
    Proc Clin Dial Transplant Forum; 1973; 3():74-6. PubMed ID: 4283133
    [No Abstract]   [Full Text] [Related]  

  • 47. Platelet survival test. A method to detect preimmunization in rabbits.
    Andersen OS; Tissot RG; Cohen C; Jonasson O
    Transplantation; 1973 Jan; 15(1):101-10. PubMed ID: 4575915
    [No Abstract]   [Full Text] [Related]  

  • 48. Posttransplant immunologic monitoring of the renal allograft recipient.
    Gailiunas P; Suthanthiran M; Person A; Strom TB; Carpenter CB; Garovoy MR
    Transplant Proc; 1978 Sep; 10(3):609-11. PubMed ID: 362644
    [No Abstract]   [Full Text] [Related]  

  • 49. Specific inhibition of cardiac allograft rejection.
    Jenkins AM; Sanders JH; Woodruff MF
    Br J Surg; 1971 Nov; 58(11):859. PubMed ID: 4942030
    [No Abstract]   [Full Text] [Related]  

  • 50. Enhancing antibody in human renal transplantation.
    Iwaki Y; Terasaki PI; Heintz R; Cardman L; Hermes M
    Transplant Proc; 1979 Dec; 11(4):1899-902. PubMed ID: 394435
    [No Abstract]   [Full Text] [Related]  

  • 51. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ; Harmer AW; Koffman CG; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract]   [Full Text] [Related]  

  • 53. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 54. B-cell directed antibodies and delayed hyperacute rejection: a case report.
    Buckingham JM; Geis WP; Giacchino JL; Popli S; Hano JE; Chejfec G; Jonasson O
    J Surg Res; 1979 Oct; 27(4):268-74. PubMed ID: 384089
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antibody formation in patients and the time periods of kidney allograft functioning].
    Tsygankova ST; Belorusov OS; Boĭko OV
    Sov Med; 1984; (1):39-43. PubMed ID: 6367088
    [No Abstract]   [Full Text] [Related]  

  • 56. Antibody responses in kidney transplant recipients and graft survival.
    Jeannet M; Klouda PT; Werner C; Vassalli P; Legendre C; Ramirez E
    Transplant Proc; 1977 Mar; 9(1):747-50. PubMed ID: 325808
    [No Abstract]   [Full Text] [Related]  

  • 57. [Role of prostaglandins in the immune response].
    Dy M
    Nouv Presse Med; 1979 Jun; 8(27):2243-6. PubMed ID: 315055
    [No Abstract]   [Full Text] [Related]  

  • 58. The detection and measurement of pretransplant sensitization.
    Carpenter CB; Morris PJ
    Transplant Proc; 1978 Jun; 10(2):509-13. PubMed ID: 150085
    [No Abstract]   [Full Text] [Related]  

  • 59. Cold and warm B-cell antibodies in renal transplantation.
    Ting A; Morris PJ
    Lancet; 1978 Aug; 2(8087):478. PubMed ID: 79845
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cold lymphocytotoxins in kidney graft recipients].
    Roy R; Robert M; Lachance JG; Daguillard F
    Union Med Can; 1977 Mar; 106(3):297-300. PubMed ID: 324066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.